Edition:
United Kingdom

Unichem Laboratories Ltd (UNLB.NS)

UNLB.NS on National Stock Exchange of India

261.15INR
18 May 2018
Change (% chg)

Rs-6.15 (-2.30%)
Prev Close
Rs267.30
Open
Rs267.15
Day's High
Rs267.15
Day's Low
Rs260.30
Volume
34,282
Avg. Vol
231,706
52-wk High
Rs382.00
52-wk Low
Rs231.00

Chart for

About

Unichem Laboratories Limited is a pharmaceutical company. The Company manufactures active pharmaceutical ingredients (APIs or bulk actives). In addition, it has various pharma products for addressing therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and... (more)

Overall

Beta: 0.56
Market Cap(Mil.): Rs23,875.38
Shares Outstanding(Mil.): 90.92
Dividend: 3.00
Yield (%): 1.14

Financials

  UNLB.NS Industry Sector
P/E (TTM): 82.70 30.95 32.75
EPS (TTM): 3.18 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.07

BRIEF-Unichem Laboratories Gets ANDA Approval From U.S. FDA For Valsartan Tablets, USP

* SAYS GOT ANDA APPROVAL FROM USFDA FOR VALSARTAN TABLETS, USP

07 May 2018

BRIEF-Unichem Laboratories Seeks Shareholders' Nod For Share Buyback Proposal

* SEEKS SHAREHOLDERS' NOD FOR SHARE BUYBACK PROPOSAL WORTH 8.86 BILLION RUPEES Source text - http://bit.ly/2mik1mO Further company coverage:

10 Jan 2018

BRIEF-Unichem Labs Dec-qtr Profit Rises

* DEC QUARTER PROFIT 25.07 BILLION RUPEES VERSUS 261.1 MILLION RUPEES YEAR AGO

08 Jan 2018

BRIEF-Unichem Laboratories To Consider Proposal To Buy-Back Shares Of Co

* SAYS TO CONSIDER PROPOSAL TO BUY-BACK SHARES OF CO Source text - http://bit.ly/2CxeEdf Further company coverage:

03 Jan 2018

BRIEF-Torrent Pharma Completes Acquisition Of Branded Formulation Business Of Unichem Labs

* SAYS TORRENT PHARMACEUTICALS LIMITED COMPLETES ACQUISITION OF BRANDED FORMULATION BUSINESS OF UNICHEM LABORATORIES LIMITED Source text: http://bit.ly/2krSQVo Further company coverage:

14 Dec 2017

Earnings vs. Estimates